scholarly journals HHV8 Infection

2020 ◽  
Author(s):  
Keyword(s):  
2017 ◽  
Vol 43 (1) ◽  
pp. 79-82 ◽  
Author(s):  
J.-L. Nguewa ◽  
E. Lontchi-Yimagou ◽  
F. Agbelika ◽  
M. AitDjoudi ◽  
P. Boudou ◽  
...  

2013 ◽  
Vol 13 (6) ◽  
pp. 1619-1620 ◽  
Author(s):  
G. Riva ◽  
P. Barozzi ◽  
C. Quadrelli ◽  
D. Vallerini ◽  
E. Zanetti ◽  
...  

2000 ◽  
Vol 151 (3) ◽  
pp. 230-230 ◽  
Author(s):  
N. H. T. M. Dukers ◽  
R. A. Coutinho ◽  
J. Goudsmit

2004 ◽  
Vol 40 ◽  
pp. 54
Author(s):  
A.M. Roque-Afonso ◽  
A.G. Marcelin ◽  
E. Kimmoun ◽  
M. Hurtova ◽  
M. Tulliez ◽  
...  
Keyword(s):  

2000 ◽  
Vol 41 (2) ◽  
pp. 125-129 ◽  
Author(s):  
T.F. Schulz
Keyword(s):  

2021 ◽  
Vol 26 (1) ◽  
Author(s):  
Xiao Cui ◽  
Yongfeng Wu ◽  
Lin Jia ◽  
Jing Chang ◽  
Chuanyun Li ◽  
...  

Abstract Background For a patient presenting with fever, multiple lymphadenopathy and splenomegaly, pathogen infection should be preferentially considered, followed by lymphoid malignancies. When traditional laboratory and pathological detection cannot find the pathogenic microorganism, metagenomic sequencing (MGS) which targets the person’s genome for exceptional genetic disorders may detect a rare pathogen. Case presentation Here, we introduced the diagnostic clue of a case of multicentric Castleman disease (MCD) with hemophagocytic syndrome which was elicited from the detection of human herpesvirus-8 in the blood of a HIV-1 infected person by MGS technology during pathogen inspection. This case highlights the need to increase the awareness of MCD among clinicians and pathologists. Conclusions MGS technology may play a pivotal role in providing diagnostic clues during pathogen inspection, especially when pathogens are not detectable by conventional methods.


2005 ◽  
Vol 202 (4) ◽  
pp. 479-484 ◽  
Author(s):  
William H. Wheat ◽  
Carlyne D. Cool ◽  
Yoshikazu Morimoto ◽  
Pradeep R. Rai ◽  
Charles H. Kirkpatrick ◽  
...  

Patients who have common variable immunodeficiency (CVID) and granulomatous/lymphocytic interstitial lung disease (GLILD) are at high risk for early mortality and B cell lymphomas. Infection with human herpes virus type 8 (HHV8), a B cell lymphotrophic virus, is linked to lymphoproliferative disorders in people who have secondary immunodeficiencies. Therefore, we determined the prevalence of HHV8 infection in CVID patients with GLILD. Genomic DNA isolated from peripheral blood mononuclear cells was screened by nested- and real time-quantitative PCR (QRT-PCR) for the presence of HHV8 genome. It was positive in 6/9 CVID patients with GLILD (CVID-GLILD), 1/21 CVID patients without GLILD (CVID-control), and no patients receiving intravenous gamma globulin (n = 13) or normal blood donors (n = 20). Immunohistochemistry (IHC) demonstrated expression of the latency-associated nuclear antigen-1 (LANA-1) in the biopsies of the lung, liver, and bone marrow of four patients with CVID-GLILD. One CVID-GLILD patient developed a B cell lymphoma during the course of the study. QRT-PCR demonstrated high copy number of HHV8 genome and IHC showed diffuse staining for LANA-1 in the malignant lymph node. HHV8 infection may be an important factor in the pathogenesis of the interstitial lung disease and lymphoproliferative disorders in patients with CVID.


2013 ◽  
Vol 137 (2) ◽  
pp. 289-294 ◽  
Author(s):  
Oana Radu ◽  
Liron Pantanowitz

Kaposi sarcoma (KS) is a low-grade vascular tumor associated with Kaposi sarcoma herpesvirus/human herpesvirus 8 (KSHV/HHV8) infection. Kaposi sarcoma lesions predominantly present at mucocutaneous sites, but may involve all organs and anatomic locations. Recognized epidemiologic-clinical forms of KS include classic, African (endemic), AIDS-associated (epidemic), and iatrogenic KS. New clinical manifestations have been described, such as antiretroviral therapy–related KS regression or flares. Kaposi sarcoma lesions evolve from early (patch stage) macules into plaques (plaque stage) that grow into larger nodules (tumor stage). Newer histologic variants include anaplastic, hyperkeratotic, lymphangioma-like, bullous, telangiectatic, ecchymotic, keloidal, pyogenic granuloma–like, micronodular, intravascular, glomeruloid and pigmented KS, as well as KS with sarcoidlike granulomas and KS with myoid nodules. Latency-associated nuclear antigen (HHV8) is the most specific immunohistochemical marker available to help distinguish KS from its mimics. Since KS remains one of the most common AIDS-defining malignancies, it is important that pathologists be able to recognize KS and its contemporary manifestations.


Sign in / Sign up

Export Citation Format

Share Document